These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2721260)

  • 1. Clinical pharmacokinetics of theophylline and levels of alpha 1-acid glycoprotein in smokeless tobacco users.
    Parish RC; Terrell JR; Brown WJ
    Chest; 1989 Jun; 95(6):1253-6. PubMed ID: 2721260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
    Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smokeless tobacco use and health effects among baseball players.
    Ernster VL; Grady DG; Greene JC; Walsh M; Robertson P; Daniels TE; Benowitz N; Siegel D; Gerbert B; Hauck WW
    JAMA; 1990 Jul; 264(2):218-24. PubMed ID: 2355443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of risk factors in smokeless tobacco-associated oral lesions.
    Kaugars GE; Brandt RB; Chan W; Carcaise-Edinboro P
    Oral Surg Oral Med Oral Pathol; 1991 Sep; 72(3):326-31. PubMed ID: 1923420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smokeless tobacco use among adults in Kentucky: 1994.
    McKnight RH; Koetke CA; Mays JR
    J Ky Med Assoc; 1995 Oct; 93(10):459-64. PubMed ID: 8558056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native youth and smokeless tobacco: prevalence rates, gender differences, and descriptive characteristics.
    Schinke SP; Schilling RF; Gilchrist LD; Ashby MR; Kitajima E
    NCI Monogr; 1989; (8):39-42. PubMed ID: 2785650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health effects of smokeless tobacco. Council on Scientific Affairs.
    JAMA; 1986 Feb; 255(8):1038-44. PubMed ID: 3511319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smokeless tobacco: the health consequences of snuff and chewing tobacco.
    Goolsby MJ
    Nurse Pract; 1992 Jan; 17(1):24, 28, 31, passim. PubMed ID: 1538836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of smokeless tobacco use: a national study.
    Rouse BA
    NCI Monogr; 1989; (8):29-33. PubMed ID: 2785648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral effects of smokeless tobacco use by professional baseball players.
    Robertson PB; Walsh MM; Greene JC
    Adv Dent Res; 1997 Sep; 11(3):307-12. PubMed ID: 9524430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of smokeless tobacco use among high school football players as related to type of smokeless tobacco and period of use.
    Creath CJ; Wright JT; Wisniewski JF
    J Drug Educ; 1992; 22(1):69-85. PubMed ID: 1593389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum.
    Benowitz NL; Porchet H; Sheiner L; Jacob P
    Clin Pharmacol Ther; 1988 Jul; 44(1):23-8. PubMed ID: 3391001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and analysis of tobacco-specific N-nitrosamines.
    Brunnemann KD; Prokopczyk B; Djordjevic MV; Hoffmann D
    Crit Rev Toxicol; 1996; 26(2):121-37. PubMed ID: 8688156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral mucosal smokeless tobacco lesions among adolescents in the United States.
    Tomar SL; Winn DM; Swango PA; Giovino GA; Kleinman DV
    J Dent Res; 1997 Jun; 76(6):1277-86. PubMed ID: 9168861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of smokeless tobacco and cigarettes--effects on plasma levels of antioxidant vitamins.
    Stegmayr B; Johansson I; Huhtasaari F; Moser U; Asplund K
    Int J Vitam Nutr Res; 1993; 63(3):195-200. PubMed ID: 8300330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smokeless tobacco and theophylline clearance.
    Rockwood R; Henann N
    Drug Intell Clin Pharm; 1986; 20(7-8):624-5. PubMed ID: 3743424
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum total sialic acid levels in smokers and users of smokeless tobacco in form of oral powder (Maraş powder).
    Kurtul N; Cil MY; Paçaci SD
    J Biomed Sci; 2005; 12(3):559-63. PubMed ID: 15959629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users.
    Bolinder G; de Faire U
    Am J Hypertens; 1998 Oct; 11(10):1153-63. PubMed ID: 9799031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality traits of smokeless tobacco users and nonusers: a comparison.
    Edmundson EW; Glover ED; Alston PP; Holbert D
    Int J Addict; 1987 Jul; 22(7):671-83. PubMed ID: 3623750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smokeless tobacco use and oral pathology in a professional baseball organization.
    Sinusas K; Coroso JG; Sopher MD; Crabtree BF
    J Fam Pract; 1992 Jun; 34(6):713-8. PubMed ID: 1593245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.